Politisphere

S. 1702: Access to Prescription Digital Therapeutics Act of 2025

A Senate bill (S.) in the 119th U.S. Congress.

Overview

Congress119th U.S. Congress (2025–2026)
TypeSenate bill (S.)
Originating chamberSenate
Introduced2025-05-08
SponsorSen. Capito, Shelley Moore [R-WV]
Policy areaHealth
Cosponsors4
Latest action2025-05-08 — Read twice and referred to the Committee on Finance.
Last updated2026-06-17

Summary

Official summary (Introduced in Senate, 2025-05-08):

Access to Prescription Digital Therapeutics Act of 2025

This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.

Cosponsors (4)

NameParty / state
Jeanne Shaheen D NH (original cosponsor) 2025-05-08
Cory A. Booker D NJ 2025-07-15
Ted Budd R NC 2025-12-10
Marsha Blackburn R TN 2026-06-16

Full text & official record

The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 1702 are published by Congress on congress.gov.

View S. 1702 on congress.gov →

Frequently asked questions

What is S. 1702?

S. 1702 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Access to Prescription Digital Therapeutics Act of 2025.

Where can I read the full bill text?

The full text, cosponsors, amendments, and legislative status for S. 1702 are available on congress.gov.

Bill data: congress.gov API (official congressional records).